PolyA RNA-seq from liposarcoma cells treated with Nutlin3R and/or Carfilzomib
Analysis of steady-state mRNA levels in liposarcoma cells treated for 28 hr with 0.05% DMSO or 10 uM Nutlin3R and/or 12.5 nM Carfilzomib Overall design: Two independent biological replicates each of 94T778 and Lipo-246 cells, treated for 28 hr with 0.05% DMSO or 10 uM Nutlin3R and/or 12.5 nM Carfilzomib